Opinion statement
The incidence of vascular access site related complications ranges between 0.8 % to 1.8 % of diagnostic cardiac catheterization and up to 9 % of percutaneous coronary interventions (PCI) [1]. The femoral vessels at the groin are used as the access site for the majority of percutaneous coronary, peripheral arterial and venous, and electrophysiologic interventions. With emergence of endovascular abdominal aortic aneurysm repair (EVAR), thoracic endovascular aneurysm repair (TEVAR), and transcatheter aortic valve replacement (TAVR), larger access sheaths (up to 18Fr–24Fr) are required, which further increases the potential for access site complications. The true incidence of access site complications arising from non-coronary interventions is unknown; hence it is likely that the total incidence of vascular access site complications is greatly underestimated. Vascular closure devices (VCDs), radial artery access, fluoroscopic guidance, and ultrasound guidance have all been used with a hope to minimize these complications. Despite these attempts, vascular access complications have not been eliminated. Cardiovascular specialists must promptly identify these complications and manage them appropriately.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Arora N, Matheny ME, Sepke C, Resnic FS. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J. 2007;153(4):606–11.
Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. JACC Cardiovasc Interv. 2008;1(3):317–26.
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463–654. This is a consensus document for management of peripheral arterial disease. Important document for all practicing cardiovascular documents.
Morgan R, Belli AM. Current treatment methods for postcatheterization pseudoaneurysms. J Vasc Intervent Radiol. 2003;14(6):697–710.
Coughlin BF, Paushter DM. Peripheral pseudoaneurysms: evaluation with duplex US. Radiology. 1988;168(2):339–42.
Finkelstein A, Bazan S, Halkin A, Herz I, George J, Miller HI, et al. Treatment of post-catheterization femoral artery pseudo-aneurysm with para-aneurysmal saline injection. Am J Cardiol. 2008;101(10):1418–22.
La Perna L, Olin JW, Goines D, Childs MB, Ouriel K. Ultrasound-guided thrombin injection for the treatment of postcatheterization pseudoaneurysms. Circulation. 2000;102(19):2391–5. Important document that reported the "3-way stopcock technique".
Webber GW, Jang J, Gustavson S, Olin JW. Contemporary management of postcatheterization pseudoaneurysms. Circulation. 2007;115(20):2666–74.
Kelm M, Perings SM, Jax T, Lauer T, Schoebel FC, Heintzen MP, et al. Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: implications for risk stratification and treatment. J Am Coll Cardiol. 2002;40(2):291–7. Prospective study regarding AV Fistula incidence and natural history.
Onal B, Ilgit ET, Akpek S, Coskun B. Postcatheterization femoral arteriovenous fistula: endovascular treatment with N-butyl-cyanoacrylate embolization. Cardiovasc Intervent Radiol. 2006;29(2):276–8.
Zhou T, Liu ZJ, Zhou SH, Shen XQ, Liu QM, Fang ZF, et al. Treatment of postcatheterization femoral arteriovenous fistulas with simple prolonged bandaging. Chin Med J (Engl). 2007;120(11):952–5.
Stigall KE, Dorsey JS. Late complications of traumatic arteriovenous fistula. Case report and overview. Am Surg. 1989;55(3):180–3.
Schaub F, Theiss W, Heinz M, Zagel M, Schomig A. New aspects in ultrasound-guided compression repair of postcatheterization femoral artery injuries. Circulation. 1994;90(4):1861–5.
Vaninbroukx I, Vandekerkhof J. Endovascular stent graft treatment for iatrogenic arteriovenous fistulas after femoral catheterisation. Acta Chir Belg. 2004;104(5):584–7.
Jackson JE, Mansfield AO, Allison DJ. Treatment of high-flow malformations by venous embolization aided by flow occlusion techniques. Cardiovasc Interv Radiol. 1996;19(5):323–8.
Thalhammer C, Kirchherr AS, Uhlich F, Waigand J, Gross CM. Postcatheterization pseudoaneurysms and arteriovenous fistulas: repair with percutaneous implantation of endovascular covered stents. Radiology. 2000;214(1):127–31.
Sovik E, Klow NE, Brekke M, Stavnes S. Elective placement of covered stents in native coronary arteries. Acta Radiol. 2003;44(3):294–301.
Tsetis DK, Kochiadakis GE, Hatzidakis AA, Skalidis EI, Chryssou EG, Tritou IN, et al. Transcatheter thrombolysis with high-dose bolus tissue plasminogen activator in iatrogenic arterial occlusion after femoral arterial catheterization. Cardiovasc Intervent Radiol. 2002;25(1):36–41.
Prasad A, Compton PA, Roesle M, Makke L, Rogers S, Banerjee S, et al. Incidence and treatment of arterial access dissections occurring during cardiac catheterization. J Interv Cardiol. 2008;21(1):61–6.
Tsetis D. Endovascular treatment of complications of femoral arterial access. Cardiovasc Intervent Radiol. 2010;33(3):457–68.
Kim MC. Vascular closure devices. Cardiol Clin. 2006;24(2):277–86. vii.
Silva JA, White CJ, Quintana H, Collins TJ, Jenkins JS, Ramee SR. Percutaneous revascularization of the common femoral artery for limb ischemia. Cathet Cardiovasc Intervent. 2004;62(2):230–3.
Yatskar L, Selzer F, Feit F, Cohen HA, Jacobs AK, Williams DO, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Cathet Cardiovasc Intervent. 2007;69(7):961–6.
Sreeram S, Lumsden AB, Miller JS, Salam AA, Dodson TF, Smith RB. Retroperitoneal hematoma following femoral arterial catheterization: a serious and often fatal complication. Am Surg. 1993;59(2):94–8.
Kent KC, Moscucci M, Mansour KA, DiMattia S, Gallagher S, Kuntz R, et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg. 1994;20(6):905–10. discussion 10–3.
Bhatty S, Cooke R, Shetty R, Jovin IS. Femoral vascular access-site complications in the cardiac catheterization laboratory: diagnosis and management. Interv Cardiol. 2011;3(4):503–14.
Ellis SG, Bhatt D, Kapadia S, Lee D, Yen M, Whitlow PL. Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Cathet Cardiovasc Intervent. 2006;67(4):541–5.
Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Cathet Cardiovasc Intervent. 2005;65(2):196–202.
Trimarchi S, Smith DE, Share D, Jani SM, O'Donnell M, McNamara R, et al. Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry. JACC Cardiovasc Interv. 2010;3(8):845–50.
Levine GN, Kern MJ, Berger PB, Brown DL, Klein LW, Kereiakes DJ, et al. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med. 2003;139(2):123–36.
Zahn R, Fromm E, Thoma S, Lotter R, Zander M, Wagner S, et al. Local venous thrombosis after cardiac catheterization. Angiology. 1997;48(1):1–7.
Kolluri R, Pinedo D, Goldstein JA, Goswami NJ, Mishkel G. Deep venous thromboses in association with catheterization. J Am Coll Cardiol. 2008;51(Suppl B)(10):B94–B.
Jang JJ, Kim M, Gray B, Bacharach JM, Olin JW. Claudication secondary to Perclose use after percutaneous procedures. Cathet Cardiovasc Intervent. 2006;67(5):687–95.
Boston US, Panneton JM, Hofer JM, Sabater EA, Caplice N, Rowland CM, et al. Infectious and ischemic complications from percutaneous closure devices used after vascular access. Ann Vasc Surg. 2003;17(1):66–71.
Seldinger SI. Catheter replacement of the needle in percutaneous arteriography. A new technique. Acta Radiol Suppl. 2008;434:47–52.
Seto AH, Abu-Fadel MS, Sparling JM, Zacharias SJ, Daly TS, Harrison AT, et al. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). JACC Cardiovasc Interv. 2010;3(7):751–8.
Disclosure
Dr. Raghu Kolluri is on the Medical Advisory Board of Bard Inc. Dr. Kolluri received consultancy and payment for the development of educational presentations including service on speakers’ bureaus from Covidien Vascular Therapies and Cook Medical. Dr. Brian Fowler received consultancy from Covidien Vascular Therapies. Dr. Shailesh Nandish reported no conflicts of interest relevant to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kolluri, R., Fowler, B. & Nandish, S. Vascular Access Complications: Diagnosis and Management. Curr Treat Options Cardio Med 15, 173–187 (2013). https://doi.org/10.1007/s11936-013-0227-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11936-013-0227-8